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Abstract
The food enzyme considered in this opinion is a pullulanase (pullulan 6-a-glucanohydrolase; EC
3.2.1.41), produced with the genetically modiﬁed Bacillus subtilis strain NZYM-AK by Novozymes A/S
(Denmark). The pullulanase food enzyme is intended to be used in starch processing for the
production of glucose syrups. Since the residual amounts of total organic solids (TOS) in glucose
syrups after ﬁltration and puriﬁcation during starch processing were considered negligible, no dietary
exposure was calculated. Genotoxicity tests made with the food enzyme indicated no genotoxic
concern. A repeated dose 90-day oral toxicity study in rodents, carried out with a pullulanase produced
with a predecessor strain, showed no concern with respect to systemic toxicity. The allergenicity was
evaluated by searching for similarity of the amino acid sequence to those of known allergens; no
match was found. The Panel considers that there are no indications for allergic reactions. Based on the
microbial source, genetic modiﬁcations performed, the manufacturing process, the compositional and
biochemical data provided, the ﬁndings in the toxicological studies and allergenicity assessment, the
Panel concludes that this food enzyme does not give rise to safety concerns under the intended
conditions of use.
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1. Introduction
Article 3 of the Regulation (EC) No 1332/20081 provides deﬁnition for ‘food enzyme’ and ‘food
enzyme preparation’.
‘Food enzyme’ means a product obtained from plants, animals or microorganisms or products thereof
obtained by a fermentation process using microorganisms: (i) containing one or more enzymes capable of
catalysing a speciﬁc biochemical reaction; and (ii) added to food for a technological purpose at any stage
of the manufacturing, processing, preparation, treatment, packaging, transport or storage of foods.
‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in which
substances such as food additives and/or other food ingredients are incorporated to facilitate their
storage, sale, standardisation, dilution or dissolution.
Before January 2009, food enzymes other than those used as food additives were not regulated or
were regulated as processing aids under the legislation of the Member States. On 20 January 2009,
Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes
that are added to food to perform a technological function in the manufacture, processing,
preparation, treatment, packaging, transport or storage of such food, including enzymes used as
processing aids. Regulation (EC) No 1331/20082 established the European Union (EU) procedures for
the safety assessment and the authorisation procedure of food additives, food enzymes and food
ﬂavourings. The use of a food enzyme shall be authorised only if it is demonstrated that:
• it does not pose a safety concern to the health of the consumer at the level of use proposed,
• there is a reasonable technological need, and
• its use does not mislead the consumer.
All food enzymes currently on the EU market and intended to remain on that market, as well as all
new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority
(EFSA) and approval via an EU Community list.
The ‘Guidance on submission of a dossier on a food enzyme for evaluation’ (EFSA, 2009a) lays
down the administrative, technical and toxicological data required.
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background as provided by the European Commission
Only food enzymes included in the European Union (EU) Community list may be placed on the
market as such and used in foods, in accordance with the speciﬁcations and conditions of use provided
for in Article 7 (2) of Regulation (EC) No 1332/2008 on food enzymes. According to this Regulation, a
food enzyme that falls within the scope of Regulation (EC) No 1829/20033 on genetically modiﬁed food
and feed should be authorised in accordance with that Regulation as well as under this Regulation.
An application has been introduced by Novozymes A/S for authorisation of the food enzyme
pullulanase obtained by fermentation with the genetically modiﬁed Bacillus subtilis NZYM-AK.
Following the requirements of Article 12.1 of Commission Regulation (EU) No 234/20114
implementing Regulation (EC) No 1331/2008, the Commission has veriﬁed that the application falls
within the scope of the food enzyme Regulation and contains all the elements required under Chapter
II of that Regulation.
1.1.2. Terms of Reference
The European Commission requests EFSA to carry out the safety assessment on the food enzyme
pullulanase obtained with the genetically modiﬁed Bacillus subtilis strain NZYM-AK in accordance with
Article 17.3 of Regulation (EC) No 1332/2008 on food enzymes.
1 Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and
Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive 2001/
112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, p. 7–15.
2 Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common
authorisation procedure for food additives, food enzymes and food ﬂavourings. OJ L 354, 31.12.2008, p. 1–6.
3 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. OJ L 268, 18.10.2003, p. 1–23.
4 Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European
Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food
ﬂavourings. OJ L 64, 11.3.2011, p. 15–24.
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1.2. Information on existing authorisation and evaluations
According to the applicant, the French and Danish food authorities have evaluated and authorised
the use of pullulanase from a predecessor production strain in the same strain lineage, in a number of
food and beverage manufacturing processes. The Danish authorities specify the conditions of use,
including the dosage for speciﬁc foods, which were up to a level of 675 pullulanase units NPUN5/kg
starch for glucose syrup, beer and beverage alcohol.
2. Data and methodologies
2.1. Data
The applicant has submitted a dossier in support of the application for authorisation of the food
enzyme pullulanase produced with a genetically modiﬁed B. subtilis (strain NZYM-AK). The food
enzyme is intended for use in starch processing for the production of glucose syrups.6
2.2. Methodologies
The assessment was conducted in line with the principles described in the EFSA Guidance on
transparency in the scientiﬁc aspects of risk assessment (EFSA, 2009b) and following the relevant
Guidances from the EFSA Scientiﬁc Committee.
The current guidance on the submission of a dossier for safety evaluation of a food enzyme (EFSA,
2009a) has been followed by the CEF Panel for the evaluation of the application with the exception of
the exposure assessment, which was carried out in accordance to the methodology described in the
CEF Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel, 2016).
3. Assessment
3.1. Technical data
3.1.1. Identity of the food enzyme
IUBMB nomenclature: Pullulanase
Systematic name: Pullulan 6-a-glucanohydrolase
Synonyms: a-Dextrin endo-1,6-a-glucosidase, amylopectin 6-glucanohydrolase
IUBMB No: EC 3.2.1.41
CAS No: 9075-68-7
EINECS No: 232-983-9.
3.1.2. Chemical Parameters
The pullulanase produced with the genetically modiﬁed Bacillus subtilis strain NZYM-AK is a single
polypeptide of 928 amino acids. The molecular mass of 101.5 kDa was deduced from the amino acid
sequence. The protein homogeneity of the food enzyme was investigated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) analysis. The gel showed a single major protein band
at about 100 kDa, together with a number of other bands with lower staining intensity.
The food enzyme was tested for other enzyme activities in the food enzyme product, i.e.
a-amylase, glucoamylase, lipase and protease, which were below the limits of detection. No other
enzymatic side activities have been reported by the applicant.
Data on the chemical parameters of the food enzyme have been provided for three commercial
food enzyme batches and one batch to be used for toxicological tests (Table 1). The average total
organic solids (TOS) content of the three commercial food enzyme batches was 11.6%; the values
ranged from 10.5% to 13.0%.
The average enzyme activity/TOS ratio of the batches was 64 New Pullulanase Unit Novozymes per
mg TOS (NPUN/mg TOS), see Section 3.1.3; the values ranged from 46 to 77 NPUN/mg TOS (Table 1).
5 New Pullulanase Unit Novozymes (see Section 3.1.2).
6 European Commission working document describing the food processes in which food enzymes are intended to be used - not
yet published at the time of adoption of this opinion.
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The applicant provided analytical data on potential contaminants in the three commercial batches
of the food enzyme and a further batch used for toxicological studies. Results showed that the lead
content (< 0.5 mg/kg) was below the speciﬁcation for lead (≤ 5 mg/kg) as laid down in the general
speciﬁcations and considerations for enzymes used in food processing (FAO/WHO, 2006). Furthermore,
the levels of arsenic, cadmium and mercury were below their respective levels of detection (As:
0.3 mg/kg; Cd, Hg: 0.05 mg/kg). No antimicrobial activity was detected in any of these batches (FAO/WHO,
2006).
The food enzyme complies with the microbiological criteria as laid down in the general
speciﬁcations and considerations for enzymes used in food processing (FAO/WHO, 2006), which
stipulate that Escherichia coli and Salmonella species are absent in 25 g of sample and total coliforms
are not more than 30 colony forming units (CFU) per gram.
The applicant has provided information on the identities of the antifoam agents used. Taking into
account the nature and properties of the antifoam agents, the manufacturing process and the quality
assurance system implemented by the applicant, the Panel considers their use as of no safety concern.
The Panel considered the compositional data provided for the food enzyme as sufﬁcient.
3.1.3. Properties of the food enzyme
The pullulanase catalyses the hydrolysis of 1,6-ɑ-D-glucosidic linkages in pullulan and partially
hydrolysed amylopectin as well as ɑ- and b-amylase limit dextrins of amylopectin, resulting in the
generation of maltotetraose and maltotriose with reducing carbohydrate ends.
The pullulanase activity is quantiﬁed in a multistep reaction. In the ﬁrst step, the enzyme is added
to borohydride (BH4), reduced pullulan (5.3 g/L) in buffer (pH 5.0, 50°C, 9 min), resulting in the
hydrolysis of 1,6-ɑ-D-glucosidic linkages and release of maltotriose units. The reaction is stopped by
the addition of a buffer containing a glucokinase (pH 9.6). This phosphorylates glucose to the non-
reducing D-glucose-6-phosphate, leaving maltotriose as the only source of reducing groups. Then
bismuth acetate/p-hydroxy-benzoic acid hydrazide reacts with the reducing groups of maltotriose,
generating a yellow complex measured at 405 nm. The activity is expressed as NPUN/g. The
international unit correspondence is described as follows: 1 NPUN = 0.35 PUN (Pullulanase Unit
Novozymes), where 1 PUN is deﬁned as the amount of enzyme, which under the standard conditions
releases 1 lmol of glucose per minute.
The effect of temperature and pH on the activity of pullulanase has been characterised.
The enzyme is active at temperatures at least up to 60°C (with an optimum of 50°C, at pH 5.5). The
pullulanase exhibits activity in the pH range 4.0–7.0 (with an optimum of pH 6.0, at 30°C).
The thermostability of the pullulanase was tested after a 30 min pre-incubation (pH 5.5). The enzyme
stability decreases rapidly above 60°C, with no enzymatic activity remaining at 70°C. The activity itself
was measured under standard assay conditions.
3.1.4. Information of the microbial source material
3.1.4.1. Information relating to the genetically modiﬁed microorganism
The pullulanase production strain Bacillus subtilis NZYM-AK is deposited in the DSMZ with the
deposit number
Table 1: Compositional data of the food enzyme
Parameter Units
Batches
1 2 3 4(a)
Pullulanase activity NPUN/g batch(b) 9,140 8,050 5,240 8,070
Protein % 6.6 5.8 5.3 NA(c)
Ash % 2.2 1.8 2.0 2.3
Water % 84.8 87.7 86.6 85.8
Total Organic Solids (TOS)(d) % 13.0 10.5 11.4 11.9
Pullulanase activity/mg TOS NPUN/mg TOS 70 77 46 68
(a): Batch for the Genotoxicity studies.
(b): NPUN/g batch: New Pullulanase Unit Novozymes (see Section 3.1.3).
(c): NA: Not analysed.
(d): TOS calculated as 100% – % water – % ash.
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3.1.4.2. Characteristics of the recipient or parental microorganism
The parental microorganism is the bacterium B. subtilis, strain A164 .
B. subtilis species is included in the list of bacterial species considered suitable for a Qualiﬁed
Presumption of Safety (QPS) approach to safety assessment, with the qualiﬁcation that the absence of
acquired antibiotic resistance genes and toxigenic activity are veriﬁed for the speciﬁc strain used (EFSA
BIOHAZ Panel 2017a,b). The identity of the parental strain has been conﬁrmed. The parental strain
has been tested for the absence of cytotoxicity in VERO cells. An intermediate strain has been tested
both in CHO-K1 (Pedersen et al., 2002) and in VERO cells. Both proved negative.
Consequently, the parental strain is presumed to be safe for production
purposes.
The recipient strain, B. subtilis , has been developed from the parental strain A164
3.1.4.3. Characteristics of the donor organisms
3.1.4.4. Description of the genetic modiﬁcation process
The production strain NZYM-AK was developed from the recipient strain
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3.1.4.5. Safety aspects of the genetic modiﬁcation
3.1.5. Manufacturing process
The food enzyme is manufactured with food safety procedures based on Hazard Analysis and
Critical Control Points (HACCP), in accordance with current Good Manufacturing Practice (GMP) and,
when produced in the EU, in accordance with the Food Hygiene Regulation (EC) 852/20047.
The food enzyme is produced by a pure culture in a contained, submerged, fed-batch fermentation
system with conventional process controls in place. The identity and the purity of the culture are
checked at each transfer step and at regular and critical steps until the end of fermentation.
The downstream processing includes recovery, puriﬁcation, concentration and stabilisation. The
food enzyme produced is recovered from the fermentation broth after biomass separation via press
ﬁltration. The liquor is then ﬁltered to remove the remaining microorganisms, and concentrated by
ultraﬁltration, which removes the low-molecular-weight material.
Subsequently, the food enzyme concentrate is formulated and commercialised as a liquid or a solid
preparation. To this end, the concentrated food enzyme solution is stabilised by the addition of
preservatives , and ﬁnally subjected to polish- and
germ-ﬁltration.
The absence of the production strain in the product was demonstrated
.
No recombinant DNA was detected in three independent batches in triplicate
The Panel considered the information provided on the raw materials and manufacturing process as
sufﬁcient.
3.1.6. Safety for the environment
Neither the production strain nor its recombinant DNA was detected in the ﬁnal product.
Accordingly, no environmental risk assessment is required (EFSA GMO Panel, 2011).
7 Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of food additives.
OJ L 226, 25.6.2004, p. 3–21.
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3.1.7. Reaction and fate in food
The pullulanase catalyses the hydrolysis of 1,6-ɑ-D-glucosidic linkages in pullulan and partially
hydrolysed amylopectin as well as ɑ- and b-amylase limit dextrins of amylopectin, resulting in the
generation of maltotetraose and maltotriose with reducing carbohydrate ends. These products are
naturally present in starch-containing foods.
The information and data provided indicate that the pullulanase is removed during processing under
the intended conditions of use (starch processing: ﬁltration, carbon treatment and ion exchange).
The food enzyme was tested for the presence of other enzyme activities, i.e. a-amylase,
glucoamylase, lipase and protease, which were below the limits of detection. No other side activities
have been reported by the applicant.
3.1.8. Case of need and proposed conditions of use
As proposed by the applicant, the food enzyme pullulanase is intended for use in starch processing
for the production of glucose syrups containing maltose, at an intended use level of up to 78.1 mg
TOS/kg starch.
In starch processing, the pullulanase is added after the liquefaction during the sacchariﬁcation step
in order to convert liqueﬁed starch into maltose-rich glucose syrups.
According to the applicant, the food enzyme is used at the minimum amount necessary to achieve
the desired reaction according to GMP. The use level applied by a food manufacture in practice
depends on the particular process.
3.2. Dietary exposure
For this application, the intended use of this pullulanase is to hydrolyse starch in order to produce
maltose-containing glucose syrups. Experimental data on the signiﬁcant removal (> 99%) of protein in
the course of this process have been provided (Documentation provided to EFSA n. 4). The
Panel considered this evidence as sufﬁcient to conclude that the presence of residual amounts of TOS
after the puriﬁcation steps applied during the production of glucose syrups, i.e. ﬁltration, ion exchange
chromatography, carbon treatment and crystallisation, is negligible. Consequently, no exposure was
calculated.
3.3. Toxicological assessment
3.3.1. Genotoxicity
Test item used for the genotoxicity studies is described in Table 1 (batch 4).
3.3.1.1. Bacterial reverse mutation test
To investigate the potential of pullulanase to induce gene mutations, a bacterial reverse mutation
assay (an Ames test) was performed according to OECD Test Guideline 471 (OECD, 1997) and
following Good Laboratory Practice (GLP). Four strains of Salmonella Typhimurium (TA1535, TA100,
TA1537 and TA98) as well as E. coli WP2uvrA were tested in the presence and absence of metabolic
activation (S9-mix). The direct ‘plate incorporation assay’ was applied using six different concentrations
of the food enzyme test substance (156, 313, 625, 1,250, 2,500 and, 5,000 lg/plate, corresponding to
approximately 18.6, 37.3, 74.4, 148.8 and 595 lg TOS/plate), appropriate positive controls, and sterile
deionised water as a negative control. Three experiments were performed. Upon treatment with food
enzyme, there was no increase in revertant colony numbers in the ﬁrst experiment, whereas signiﬁcant
increases were evident at the highest dose in tests with S. Typhimurium strain TA1535 (in the
presence and absence of S9-mix), S. Typhimurium strain TA98 and E. coli WP2uvrA (in the absence of
S9-mix) in the second experiment. To clarify the outcome of this experiment, these test series were
repeated in a third experiment and all results were clearly negative. Since the results obtained in the
second experiment were not reproducible, the Panel concluded that the food enzyme did not induce
gene mutations under the conditions employed for this study.
3.3.1.2. In vitro micronucleus assay
The in vitro micronucleus assay was carried out according to the OECD Test Guideline 487 (OECD,
2007) and following GLP. Human peripheral blood lymphocytes were exposed to the food enzyme for a
short treatment (3 h + 21 h recovery) in the presence and absence of S9-mix, and for a continuous
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treatment (24 h with no recovery) without S9-mix using a concentration range from 1,187 to 5,000
lg/mL (corresponding to 141–595 lg TOS/mL). No biologically relevant increase in the frequency of
micronuclei was observed. The Panel concluded that the food enzyme pullulanase did not induce
micronuclei under the test conditions employed.
3.3.2. Repeated dose 90-day oral toxicity study in rodents
For the repeated dose 90-day oral toxicity, a study on a pullulanase preparation isolated from a
strain developed from the intermediate strain has
been submitted. This strain differs from the ﬁnal production strain by
The applicant
states that this predecessor strain encodes the same pullulanase enzyme as is produced by NZYM-AK.
The Panel considered this, in this case, as and adequate substitution.
A repeated dose 90-day oral toxicity study in rodents was performed according to the OECD Test
Guideline 408 (OECD, 1998) and following GLP. Groups of 10 male and 10 female SPF Sprague–Dawley
rats received daily gavage of the food enzyme test substance for 90 days at dose levels of 0 (water),
10, 30 and 100% in a volume of 10 mL/kg body weight (bw) corresponding to 129, 387 and 1,285 mg
TOS/kg bw per day.
No treatment-related deaths or effects on clinical signs, changes in body weight, body weight gain,
food consumption, in ophthalmoscopic examinations, in parameters of haematology and clinical
chemistry, organ weights, and macroscopic or microscopic pathology were observed. Some changes in
urinary parameters were observed, but these were not considered of biological relevance.
The Panel concluded that the no observed adverse effect level (NOAEL) was the highest dose level
tested, which corresponds to 1,285 mg TOS/kg bw per day.
3.4. Allergenicity
The potential allergenicity of the pullulanase produced with the genetically modiﬁed B. subtilis
strain NZYM-AK was assessed by comparing its amino acid sequence with those of known allergens
according to the scientiﬁc opinion on the assessment of allergenicity of genetically modiﬁed (GM)
plants and microorganisms and derived food and feed of the Scientiﬁc Panel on Genetically Modiﬁed
Organisms (EFSA GMO Panel, 2010). Using higher than 35% identity in a sliding window of 80 amino
acids as the criterion, no match was found.
Pullulanase from B. subtilis strain NZYM-AK is not described as a potential allergen and no food
allergic reactions to this pullulanase have been reported, so there is no evidence for potential
allergenicity of this food enzyme.
According to the information provided, substances or products that may cause allergies or
intolerances (Regulation EU 1169/2011)8 are used as raw materials in the media fed to
the microorganisms. However, the proteins will be digested during the fermentation process and
consumed by the microorganisms for cell growth, cell maintenance and production of enzyme protein.
In addition, the microbial biomass and fermentation solids will be removed. Therefore, potentially
allergenic residues of these foods employed as protein sources are not expected to be present.
Taken together, the Panel considers that there are no indications for allergic reactions, and
therefore, this pullulanase produced with the genetically modiﬁed B. subtilis (strain NZYM-AK) is not of
safety concern.
Conclusions
Based on the genetic modiﬁcations performed, the manufacturing process, the compositional and
biochemical data provided, the ﬁndings in the toxicological studies and allergenicity assessment, the
Panel concludes that this food enzyme does not give rise to safety concerns under the intended
conditions of use.
8 Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food
information to consumers, amending Regulations (EC) No 1924/2006 and (EC) No 1925/2006 of the European Parliament and
of the Council, and repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/
EC, Directive 2000/13/EC of the European Parliament and of the Council, Commission Directives 2002/67/EC and 2008/5/EC
and Commission Regulation (EC) No 608/2004. OJ L 304,22.11.2011, p. 18–63.
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Documentation provided to EFSA
1) Dossier Application for authorisation of Pullulanase from a genetically modiﬁed strain of
B. subtilis (NZYM-AK), March 2015. Submitted by Novozymes A/S (Denmark).
2) Summary reports on technical, toxicological and genetic modiﬁcations data were delivered by
Hylobates Consulting/BiCT (Rome, Italy) on 5 August 2016, FoBiG GmbH (Freiburg,
Germany) on 15 August 2016 and by the Technical University of Denmark (Søborg,
Denmark) on 17 November 2016, respectively.
3) Additional information was received from Novozymes A/S on January 2017.
4) Additional information on “Food enzyme removal during the production of cereal based
distilled alcoholic beverages” and “Food enzyme carry/over in glucose syrups”. February
2017. Provided by the Association of Manufacturers and Formulators of Enzyme Products.
References
EFSA (European Food Safety Authority), 2009a. Guidance of EFSA prepared by the Scientiﬁc Panel of Food Contact
Material, Enzymes, Flavourings and Processing Aids on the Submission of a Dossier on Food Enzymes. The
EFSA Journal 2009;7(5):1305. 26 pp. https://doi.org/10.2903/j.efsa.2009.1305
EFSA (European Food Safety Authority), 2009b. Guidance of the Scientiﬁc Committee on Transparency in the
Scientiﬁc Aspects of Risk Assessments carried out by EFSA. Part 2: General Principles. EFSA Journal 2009;7(5):
1051, 22 pp. https://doi.org/10.2903/j.efsa.2009.1051
EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), Ricci A, Allende A, Bolton D, Chemaly M, Davies R,
Girones R, Koutsoumanis K, Herman L, Lindqvist R, Nørrung B, Robertson L, Ru G, Sanaa M, Simmons M,
Skandamis P, Snary E, Speybroeck N, Ter Kuile B, Threlfall J, Wahlstr€om H, Cocconcelli PS, Klein G (deceased),
Peixe L, Maradona MP, Querol A, Suarez JE, Sundh I, Vlak J, Correia S and Fernandez Escamez PS, 2017a.
Statement on the update of the list of QPS-recommended biological agents intentionally added to food or feed
as notiﬁed to EFSA 5: suitability of taxonomic units notiﬁed to EFSA until September 2016. EFSA Journal
2017;15(3):4663, 20 pp. https://doi.org/10.2903/j.efsa.2017.4663
EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), Ricci A, Allende A, Bolton D, Chemaly M, Davies R,
Girones R, Herman L, Koutsoumanis K, Lindqvist R, Nørrung B, Robertson L, Ru G, Sanaa M, Simmons M,
Skandamis P, Snary E, Speybroeck N, Ter Kuile B, Threlfall J, Wahlstr€om H, Cocconcelli PS, Klein G (deceased),
Prieto Maradona M, Querol A, Peixe L, Suarez JE, Sundh I, Vlak JM, Aguillera-Gomez M, Barizzone F, Brozzi R,
Correia S, Heng L, Istace F, Lythgo C and Fernandez Escamez PS, 2017b. Scientiﬁc Opinion on the update of
the list of QPS-recommended biological agents intentionally added to food or feed as notiﬁed to EFSA. EFSA
Journal 2017;15(3):4664, 177. https://doi.org/10.2903/j.efsa.2017.4664
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), Silano V,
Bolognesi C, Castle L, Cravedi J-P, Fowler P, Franz R, Grob K, G€urtler R, Husøy T, Karenlampi S, Mennes W,
Milana MR, Penninks A, Smith A, Tavares Pocas MF, Tlustos C, Wolﬂe D, Zorn H, Zugravu C-A, Arcella D, Liu Y
and Engel K-H, 2016. Panel statement on the exposure assessment of food enzymes. EFSA Journal 2016;14
(11):4581, 9 pp. https://doi.org/10.2903/j.efsa.2016.4581
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2010. Draft Scientiﬁc Opinion on the
assessment of allergenicity of GM plants and microorganisms and derived food and feed. EFSA Journal 2010;8
(7):1700, 168 pp. https://doi.org/10.2903/j.efsa.2010.1700
EFSA GMO Panel (EFSA Panel on Genetically Modiﬁed Organisms), 2011. Scientiﬁc Opinion on Guidance on the risk
assessment of genetically modiﬁed microorganisms and their products intended for food and feed use. EFSA
Journal 2011;9(6):2193, 54 pp. https://doi.org/10.2903/j.efsa.2011.2193
FAO/WHO (Food and Agriculture Organization of the United States/World Health Organization), 2006. General
speciﬁcations and considerations for enzyme preparations used in food processing in Compendium of food
additive speciﬁcations. 67th meeting. FAO JECFA Monographs 3, pp. 63–67. Available online: ftp://ftp.fao.org/
docrep/fao/009/a0675e/a0675e00.pdf
OECD (Organisation for Economic Co-operation and Development), 1997. Bacterial Reverse Mutation Test.
Guideline 471, adopted 21.07.1997. Available online: http://www.oecd-ilibrary.org/environment/test-no-471-bac
terial-reverse-mutation-test_9789264071247-en;jsessionid=9zfgzu35paaq.x-oecd-live-01
OECD (Organisation for Economic Co-operation and Development), 1998. Repeated Dose 90-day Oral Toxicity
Study in Rodents. Guideline 408, adopted 21.09.1998. Available online: http://www.oecd-ilibrary.org/environme
nt/test-no-408-repeated-dose-90-day-oral-toxicity-study-in-rodents_9789264070707-en
OECD (Organisation for Economic Co-operation and Development), 2007. In vitro micronucleus test. Draft proposal
for a new Guideline 487, adopted 13.12.2007. Available online: http://www.oecd.org/env/ehs/testing/
39780112.doc
Pedersen PB, Bjørnvad ME, Rasmussen MD and Petersen JN, 2002. Cytotoxic Potential of Industrial Strains of
Bacillus sp. Regulatory toxicology and pharmacology, 36, 155–161. https://doi.org/10.1006/rtph.2002.1574
Safety of the food enzyme pullulanase from Bacillus subtilis NZYM-AK
www.efsa.europa.eu/efsajournal 11 EFSA Journal 2017;15(8):4895
Abbreviations
bw body weight
CAS Chemical Abstracts Service
CASO Casein Soy Bean Digest
CEF EFSA Panel on Food Contact Material, Enzymes, Flavourings and Processing Aids
CFU colony forming units
CHO Chinese hamster ovaria
DSMZ Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Germany
EC Enzyme Commission
EINECS European Inventory of Existing Commercial Chemical Substances
FAO Food and Agricultural Organization
GLP Good Laboratory Practice
GM Genetically Modiﬁed
GMO Genetically Modiﬁed Organisms
GMP Good Manufacturing Practice
HACCP Hazard Analysis and Critical Control Points
IUBMB International Union of Biochemistry and Molecular Biology
JECFA Joint FAO/WHO Expert Committee on Food Additives
mRNA messenger ribonucleic acid
NOAEL no observed adverse effect level
NPUN New Pullulanase Unit Novozymes
OECD Organisation for Economic Cooperation and Development
PCR polymerase chain reaction
QPS Qualiﬁed Presumption of Safety
SDS-PAGE sodium dodecyl sulfate-poly acrylamide gel electrophoresis
TOS total organic solids
TSA Tryptic Soy Agar
WHO World Health Organization
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